CatalystPit

ANNXAnnexon, Inc.

NASDAQ · Pharmaceutical Preparations
Last close $4.23 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
RECENT INSIDER TRADES
  • 2026-09-25 · Love Douglas (PRESIDENT AND CEO) · BUY
  • 2026-05-29 · Satter Muneer A (Director) · BUY
  • 2026-05-13 · Carson William H. (Director) · BUY
  • 2026-04-14 · Carson William H. (Director) · BUY
  • 2026-03-12 · Carson William H. (Director) · BUY
INSTITUTIONAL OWNERSHIP
Institutional holders228
Shares held203,949,051
Value$1.14B
Percent of shares outstanding528.86%
As of quarter end2026-06-30
RECENT NEWS
  • Annexon: Preserving Patient Function Is The Real Investment Opportunity
  • Annexon presents vonaprument data at retina meeting
  • Annexon to Present Patient Baseline Characteristics from Vonaprument Phase 3 ARCHER II Pivotal Trial for Geographic Atrophy at The Retina Society 59th Annual Scientific Meeting
  • Annexon grants inducement awards to two new non-executive employees
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Annexon, Inc. (ANNX) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit